Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells

Clive Woffendin, Zhi Yong Yang, [No Value] Udaykumar, Ling Xu, Ning Sun Yang, Michael J. Sheehy, Gary J. Nabel

Research output: Contribution to journalArticlepeer-review

104 Scopus citations


Because AIDS has been refractory to traditional pharmacologic interventions, alternative approaches have been developed. Although the introduction of specific antiviral genes into T leukemia cells can provide relative resistance to human immunodeficiency virus (HIV) replication, the testing of such genes against primary viral isolates in human CD4+ lymphocytes has been limited, and safety questions remain regarding gene delivery into cells from HIV-infected patients. In this report, we evaluate the efficacy of a transdominant mutant protein, Rev M10, against cloned and primary HIV isolates in human peripheral blood lymphocytes and describe different methods of gene transfer into peripheral blood lymphocytes from HIV-infected individuals. We show that gold microparticles can mediate stable Rev M10 gene transfer into these cells. Introduction of Rev M10 by these techniques conferred resistance to HIV infection in vitro to cloned and clinical isolates. Nonviral delivery of HIV protective genes will facilitate the development of gene therapy for AIDS and the analysis of viral and cellular gene expression in human T lymphocytes.

Original languageEnglish (US)
Pages (from-to)11581-11585
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number24
StatePublished - Nov 22 1994
Externally publishedYes


  • AIDS
  • gene therapy
  • particle-mediated gene delivery
  • retroviral vector
  • Rev

ASJC Scopus subject areas

  • Genetics
  • General


Dive into the research topics of 'Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells'. Together they form a unique fingerprint.

Cite this